Literature DB >> 8423445

Antibody response to the M2 protein of influenza A virus expressed in insect cells.

R A Black1, P A Rota, N Gorodkova, H D Klenk, A P Kendal.   

Abstract

A recombinant baculovirus expressing the M2 protein from influenza A/Ann Arbor/6/60 (H2N2) virus (AA60 virus) was constructed. The expressed M2 protein was recognized by a monoclonal antibody specific for the M2 protein and comigrated with the M2 protein from cells infected with AA60 virus on SDS-polyacrylamide gels. Immunofluorescence studies indicated that the expressed M2 protein was present on the surface of Spodoptera frugiperda (Sf9) cells infected with the recombinant baculovirus. Immunoassays using the expressed M2 protein were able to detect antibodies to the M2 protein in serum samples from humans and ferrets infected with influenza A viruses.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8423445     DOI: 10.1099/0022-1317-74-1-143

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  45 in total

Review 1.  Influenza vaccines: from surveillance through production to protection.

Authors:  Pritish K Tosh; Robert M Jacobson; Gregory A Poland
Journal:  Mayo Clin Proc       Date:  2010-01-29       Impact factor: 7.616

Review 2.  Influenza A viruses: why focusing on M2e-based universal vaccines.

Authors:  Seyyed Mahmoud Ebrahimi; Majid Tebianian
Journal:  Virus Genes       Date:  2010-11-17       Impact factor: 2.332

3.  H5N1-SeroDetect EIA and rapid test: a novel differential diagnostic assay for serodiagnosis of H5N1 infections and surveillance.

Authors:  Surender Khurana; Pretty Sasono; Annette Fox; Van Kinh Nguyen; Quynh Mai Le; Quang Thai Pham; Tran Hien Nguyen; Thanh Liem Nguyen; Peter Horby; Hana Golding
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

4.  Enhanced influenza virus-like particle vaccines containing the extracellular domain of matrix protein 2 and a Toll-like receptor ligand.

Authors:  Bao-Zhong Wang; Harvinder S Gill; Sang-Moo Kang; Li Wang; Ying-Chun Wang; Elena V Vassilieva; Richard W Compans
Journal:  Clin Vaccine Immunol       Date:  2012-05-30

Review 5.  The threat of avian influenza A (H5N1). Part IV: Development of vaccines.

Authors:  Jindrich Cinatl; Martin Michaelis; Hans W Doerr
Journal:  Med Microbiol Immunol       Date:  2007-06-01       Impact factor: 3.402

6.  Microneedle delivery of an M2e-TLR5 ligand fusion protein to skin confers broadly cross-protective influenza immunity.

Authors:  Bao-Zhong Wang; Harvinder S Gill; Cheng He; Changbo Ou; Li Wang; Ying-Chun Wang; Hao Feng; Han Zhang; Mark R Prausnitz; Richard W Compans
Journal:  J Control Release       Date:  2014-01-11       Impact factor: 9.776

7.  Supplemented vaccination with tandem repeat M2e virus-like particles enhances protection against homologous and heterologous HPAI H5 viruses in chickens.

Authors:  Byung-Min Song; Hyun-Mi Kang; Eun-Kyoung Lee; Suk Chan Jung; Min-Chul Kim; Yu-Na Lee; Sang-Moo Kang; Youn-Jeong Lee
Journal:  Vaccine       Date:  2015-12-12       Impact factor: 3.641

Review 8.  Development of a Universal Influenza Vaccine.

Authors:  Leonardo D Estrada; Stacey Schultz-Cherry
Journal:  J Immunol       Date:  2019-01-15       Impact factor: 5.422

Review 9.  The prospects and challenges of universal vaccines for influenza.

Authors:  Kanta Subbarao; Yumiko Matsuoka
Journal:  Trends Microbiol       Date:  2013-05-17       Impact factor: 17.079

Review 10.  Virus-like particles as universal influenza vaccines.

Authors:  Sang-Moo Kang; Min-Chul Kim; Richard W Compans
Journal:  Expert Rev Vaccines       Date:  2012-08       Impact factor: 5.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.